Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biosimilar Switching Studies Show No Adverse Efficacy Or Safety Effects, Researchers Say

Mar 08 2018

• By Sue Sutter

Rail switches in yard off mainline

Related Content

Biosimilar Firms Fight Against 'Whisper Campaign' On Interchangeability

Oct 22 2017

Interchangeable Biosimilars: FDA Clarifies US Reference Not Mandatory For Studies

Oct 27 2017

US Comparator Requirement For Interchangeable Biosimilars Would Hurt Industry

Jun 01 2017

Biosimilar Non-Medical Switching: Advocacy Groups, FDA Advisors Push For Action

Jul 15 2016

Related Companies

Novartis AG

Novartis AG

Amgen, Inc.

AbbVie Inc.

Additional Topics

United States Biosimilars Biologics Drug Safety Regulation BioPharmaceutical

More from Biosimilars

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window